What is up with this next shift in culture? Lot of kaizen and continuous improvement talk within all processes including new product development and commercial. I also see it as a trend across the industry. Who is popularizing this trend in MedTech? Is it some big consulting group like McKinsey or BCG?
Is this just a response for how bad BD is doing financially, and a ruse for financial stakeholders to believe BD is changing?